Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01839695 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Valiant Mona LSA Stent Graft System
A NA study, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01839695 is a NA study that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 9 participants.
The verdict
NCT01839695, a NA study, has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The Valiant Mona LSA thoracic stent graft system is for the endovascular repair of aneurysms of the descending thoracic aorta (DTA) in patients who require coverage of the left subclavian artery (LSA).The study is intended to assess safety and performance of the device acutely and at 30 days.
Interventions
- DEVICE Valiant Mona LSA Stent Graft System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01839695
The ClinicalTrials.gov registry entry for NCT01839695 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Valiant Mona LSA Stent Graft System is the first listed.
NCT01839695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01839695 about?
NCT01839695 is a clinical study titled "Safety and Efficacy of Valiant Mona LSA Stent Graft System". The Valiant Mona LSA thoracic stent graft system is for the endovascular repair of aneurysms of the descending thoracic aorta (DTA) in patients who require coverage of the left subclavian artery (LSA).The study is intended to assess safety and performance of the device acutely and at 30 days.
What is the current status of trial NCT01839695?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2013-04. Estimated completion is 2018-12.
What interventions are being tested in trial NCT01839695?
The interventions under investigation include: Valiant Mona LSA Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT01839695?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.